1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk
(
- Contribution to journal › Article
- 2022
-
Mark
Dual antithrombotic treatment in chronic coronary syndrome : European Society of Cardiology criteria vs. CHADS-P2A2RC score
(
- Contribution to journal › Article
- 2021
-
Mark
Validation of the 4-item PRECISE-DAPT score : A SWEDEHEART study
(
- Contribution to journal › Article
-
Mark
Adherence to beta-blockers and long-term risk of heart failure and mortality after a myocardial infarction
(
- Contribution to journal › Article
-
Mark
Christmas holiday triggers of myocardial infarction
(
- Contribution to journal › Article
-
Mark
Clinical impact of intraprocedural stent thrombosis during percutaneous coronary intervention in patients treated with potent p2y12 inhibitors -A validate-swedeheart substudy
(
- Contribution to journal › Article
- 2020
-
Mark
Bivalirudin Versus Heparin Monotherapy in Elderly Patients With Myocardial Infarction : A Prespecified Subgroup Analysis of the VALIDATE-SWEDEHEART Trial
(
- Contribution to journal › Article
- 2019
-
Mark
Acute myocardial infarction. Short-term triggers, treatment optimisation and risk stratification.
(
- Thesis › Doctoral thesis (compilation)
- 2017
-
Mark
Cangrelor in combination with ticagrelor provides consistent and potent P2Y12-inhibition during and after primary percutaneous coronary intervention in real-world patients with ST-segment-elevation myocardial infarction
(
- Contribution to journal › Article